|
AU1705599A
|
|
Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
|
|
WO9912558A1
|
|
Inhibitors of collagen assembly
|
|
ZA9803331B
|
|
Method for treating protozoal infections
|
|
WO9842353A1
|
|
Modulation of human mast cell activation
|
|
WO9826802A1
|
|
Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome
|
|
US6039684A
|
|
Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome
|
|
US6265157B1
|
|
Compositions and methods for detecting altered COL1A1 gene sequences
|
|
US6025193A
|
|
Methods and compositions for diagnosis and treatment of pathological conditions related to abnormal dopamine receptor expression
|
|
WO9725860A1
|
|
Cellular immunogens useful as cancer vaccines
|
|
US5874420A
|
|
Process for regulating vagal tone
|
|
US5780432A
|
|
Therapeutic method for treatment of carcinoma or autoimmune diseases
|
|
US5981279A
|
|
Compositions and methods to regulate calmodulin gene expression, and uses thereof for influencing cell growth and differentiation
|
|
US5840692A
|
|
Peptide fragments and analogs of thrombospondin
|
|
US5840708A
|
|
Administration of oligonucleotides antisense to dopamine receptor MRNA for diagnosis and treatment of Neurological pathologies
|
